Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy in daily dialysis.

U Buoncristiani1, R Fagugli, G Ciao

  • 1UO Nefrologia-Dialisi and UO Cardiologia, Azienda Ospedaliera di Perugia, Ospedale Silvestrini, Perugia, Italy.

Mineral and Electrolyte Metabolism
|April 20, 1999
PubMed
Summary

Daily hemodialysis significantly improves cardiac hypertrophy in ESRD patients by better controlling blood pressure and anemia. This frequent dialysis schedule helps stop progression and even reverse cardiac hypertrophy toward normal levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Beyond Information: The Challenge of Innovating Communication in Nephrology, To Build Alliance and Improve Outcomes. An Overview of a Constantly Evolving Landscape].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Influence of boundary conditions on the order and defects of biaxial nematic droplets.

Physical review. E·2019
Same author

On the Defect Structure of Biaxial Nematic Droplets.

Scientific reports·2018
Same author

Nematic liquid crystals in planar and cylindrical hybrid cells: Role of elastic anisotropy on the director deformations.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015
Same author

Molecular organization of nematic liquid crystals between concentric cylinders: role of the elastic anisotropy.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015
Same author

Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.

Current medical research and opinion·2014

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiac hypertrophy is a frequent complication in End-Stage Renal Disease (ESRD) patients and a risk factor for cardiovascular death.
  • Conventional dialysis treatments often fail to adequately manage blood pressure, a key factor in cardiac hypertrophy progression.
  • ESRD patients undergoing dialysis exhibit higher rates of cardiac hypertrophy.

Purpose of the Study:

  • To evaluate the impact of daily hemodialysis on cardiac hypertrophy in uremic patients.
  • To assess the efficacy of a more frequent dialysis schedule in managing blood pressure and anemia.
  • To determine if daily hemodialysis can halt or reverse cardiac hypertrophy progression.

Main Methods:

  • Retrospective and prospective studies were conducted by the research group.

Related Experiment Videos

  • The study involved uremic patients undergoing a daily hemodialysis schedule (6-7 sessions/week, ≥2 hours per session).
  • Key parameters monitored included blood pressure control and achievement of true dry weight.

    • Main Results:

    • Daily hemodialysis demonstrated superiority in controlling blood pressure compared to conventional schedules.
    • Improvements in anemia management were observed with the daily hemodialysis regimen.
    • Studies confirmed that daily hemodialysis stopped the progression of cardiac hypertrophy and led to its reversion toward normality in uremic patients.

    Conclusions:

    • Daily hemodialysis is a more physiological and effective treatment for ESRD patients with cardiac hypertrophy.
    • Excellent blood pressure control, facilitated by easier achievement of dry weight, is the primary mechanism for reversing cardiac hypertrophy.
    • This intensified dialysis schedule offers significant cardiovascular benefits for uremic patients.